scholarly journals Interaction of sex and HIV infection on renal impairment: baseline evidence from the CHART cohort

Author(s):  
Ruizi Shi ◽  
Xiaoxiao Chen ◽  
Haijiang Lin ◽  
Weiwei Shen ◽  
Xiaohui Xu ◽  
...  
GERMS ◽  
2014 ◽  
Vol 4 (2) ◽  
pp. 29-29 ◽  
Author(s):  
Anca Streinu-Cercel

2021 ◽  
Vol 17 (1) ◽  
pp. 29-34
Author(s):  
V.D. Moskalyuk ◽  
M.O. Andrushchak ◽  
M.O. Sokolenko ◽  
I.V. Balanyuk ◽  
Y.I. Boyko

Relevance. In HIV-infected patients, renal disease, which is characterized by severe clinical manifestations, can significantly affect the prognosis of life. Given the growing number of HIV-infected people in the world and the increase in the life expectancy of such patients, an increase in the number of HIV-infected people in need of expensive renal replacement therapy, as well as kidney transplantation, should be expected. But the question of the nature of kidney damage in HIV infection in Ukraine is still insufficiently covered. The objective of the work is to establish the clinical and laboratory features of kidney damage in HIV infection. Materials and methods. 292 patients with HIV were examined. Screening for markers of kidney damage (albuminuria/proteinuria) was performed by test systems (using urine strips). The results obtained with the help of test strips were considered as indicative. In the presence of ≥1+ proteinuria in the screening test, which corresponded to a gradation of 30 mg/l, repeated urine analyzes were performed with quantitative determination of protein on a spectrophotometer, separated in time from 3 days to one week. The functional state of the kidneys was assessed by an integrated indicator that characterizes the degree of preservation/loss of mass of active nephrons. The criterion for renal impairment was a decrease in glomerular filtration rate (GFR) <60 ml/min by 1.73 m2. Chronic kidney disease was diagnosed when proteinuria or proteinuria was detected in combination with a decrease in GFR for 3 months or more. Results. Based on the main markers of renal damage (persistent proteinuria (PU) and glomerular filtration rate <60 ml/min/1.73m2), 48 people were diagnosed with chronic kidney disease, which was often accompanied by dysfunction of these organs. Based on the analysis of complaints, anamnestic data, and clinical symptoms of kidney damage, patients were divided into 2 groups. The first group (n = 31, or 64.6%) - patients with tubulointerstitial, the second group (n = 17, or 35.4%) - patients with glomerular diseases. Increased PU levels are accompanied by significantly significant renal impairment and a more frequent combination with hypertension and hematuria in the absence of significant differences in the frequency of opportunistic diseases. Conclusions. In HIV-infected kidney damage is most often characterized by their tubulointerstitial lesions. At the same time, glomerular kidney damage, which is much less common, is accompanied by significantly higher levels of HIV RNA.


Sexual Health ◽  
2020 ◽  
Vol 17 (3) ◽  
pp. 299
Author(s):  
Jack E. Heron ◽  
Suzanne Rix ◽  
Rick Varma ◽  
David M. Gracey

The use of tenofovir disoproxil fumarate (TDF) in combination with emtricitabine, prescribed for pre-exposure prophylaxis (PrEP), is highly effective at reducing incident sexually transmissible HIV infection among those at risk. TDF is associated with proteinuria, Fanconi syndrome and chronic kidney disease, and is not recommended for use in patients with an estimated creatinine clearance &lt;60 mL min−1. There are currently no Pharmaceutical Benefits Scheme (PBS)-funded PrEP options for patients at risk of HIV infection with moderate renal impairment in Australia. This report describes the case of a patient who acquired HIV soon after PrEP was suspended due to moderate renal impairment. The various clinical and regulatory issues this case raises are discussed.


PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0245383
Author(s):  
Pinky M. C. Manyau ◽  
Mensil Mabeka ◽  
Tinashe Mudzviti ◽  
Webster Kadzatsa ◽  
Albert Nyamhunga

Background There is a potential increase in risk of renal function impairment among patients with invasive cervical cancer (ICC) who are HIV-positive and treated with cisplatin-based concurrent chemoradiation (CCRT). This concern is due to overlapping nephrotoxicity of the drugs, and nephropathy from the diseases themselves. There is limited literature available for the short-term renal outcomes for HIV-positive patients with ICC during routine clinical management. This study aimed to assess if HIV-infection increased the risk of renal impairment in ICC patients treated with CCRT, and explore the respective risk factors. Materials and methods This was a retrospective review of records of ICC patients treated with at least one cycle of weekly cisplatin during CCRT at the Parirenyatwa Radiotherapy Center from January 2017-December 2018. The RIFLE criteria were used to classify renal impairment. Analyses were performed with Fisher’s Exact tests, Wilcoxon rank sum tests. Odds ratios (OR) were generated using logistic regression. All statistical tests were 2-sided at a 5% level of significance. Results Seventy-two eligible patients were identified, 32 (44.44%) were HIV-positive. HIV-positive patients were younger (p = 0.002), had lower albumin levels (p = 0.014) and received lower cisplatin doses (p = 0.044). The mean percent reduction in estimated glomerular filtration rate (eGFR) from baseline was -19% (95% CI: -25.9% to -13.2%) for all patients. Thirty-one (43.1%) patients experienced renal impairment, 50% and 37.5% of HIV-positive and -negative patients respectively (p = 0.287). HIV-infection was associated with an adjusted OR of 1.16 (95% CI 0.35–3.43, p = 0.769). Baseline eGFR< 60ml/min was the only independent predictor of renal impairment, OR 0.25 (95% CI: 0.07–0.85). Baseline eGFR<60ml/min was also associated with receipt of lower cisplatin doses (p = 0.044). Conclusion HIV-infection was not associated with elevated risk of renal impairment. Patients with an eGFR<60ml/min appear to be managed more cautiously reducing their risk for renal impairment during cisplatin therapy. The high prevalence of renal impairment in this population suggests the need for optimization of pre-treatment protocols.


Haemophilia ◽  
2001 ◽  
Vol 7 (1) ◽  
pp. 47-52 ◽  
Author(s):  
O. Katsarou ◽  
E. Terpos ◽  
E. Patsouris ◽  
P. Peristeris ◽  
N. Viniou ◽  
...  
Keyword(s):  

1996 ◽  
Vol 6 (1) ◽  
pp. 31-36 ◽  
Author(s):  
F. M. Cowan ◽  
A. M. Johnson ◽  
J. Wadsworth ◽  
M. Brennan

1987 ◽  
Vol 1 (3) ◽  
pp. 381-395 ◽  
Author(s):  
Beverly Ryan ◽  
Edward Connor ◽  
Anthony Minnefor ◽  
Frank Desposito ◽  
James Oleske

Sign in / Sign up

Export Citation Format

Share Document